nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP1A2—Clobetasol propionate—psoriasis	0.156	0.275	CbGbCtD
Aminophylline—CYP1A2—Methoxsalen—psoriasis	0.0821	0.145	CbGbCtD
Aminophylline—CYP3A4—Calcitriol—psoriasis	0.0553	0.0974	CbGbCtD
Aminophylline—CYP3A4—Methoxsalen—psoriasis	0.043	0.0757	CbGbCtD
Aminophylline—CYP2E1—Dexamethasone—psoriasis	0.0407	0.0716	CbGbCtD
Aminophylline—CYP3A4—Cholecalciferol—psoriasis	0.0285	0.0502	CbGbCtD
Aminophylline—CYP3A4—Triamcinolone—psoriasis	0.0247	0.0435	CbGbCtD
Aminophylline—CYP3A4—Mycophenolate mofetil—psoriasis	0.0247	0.0435	CbGbCtD
Aminophylline—CYP3A4—Betamethasone—psoriasis	0.0212	0.0373	CbGbCtD
Aminophylline—CYP3A4—Prednisolone—psoriasis	0.0209	0.0368	CbGbCtD
Aminophylline—CYP3A4—Hydrocortisone—psoriasis	0.0198	0.0349	CbGbCtD
Aminophylline—CYP3A4—Prednisone—psoriasis	0.0197	0.0348	CbGbCtD
Aminophylline—CYP3A4—Cyclosporine—psoriasis	0.0187	0.033	CbGbCtD
Aminophylline—CYP3A4—Dexamethasone—psoriasis	0.0123	0.0217	CbGbCtD
Aminophylline—HDAC2—Mycophenolic acid—Mycophenolate mofetil—psoriasis	0.00777	0.952	CbGdCrCtD
Aminophylline—Dermatitis—Acitretin—psoriasis	0.000447	0.00125	CcSEcCtD
Aminophylline—Rash—Fluocinolone Acetonide—psoriasis	0.000446	0.00124	CcSEcCtD
Aminophylline—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000445	0.00124	CcSEcCtD
Aminophylline—Anorexia—Mycophenolic acid—psoriasis	0.000444	0.00124	CcSEcCtD
Aminophylline—Headache—Acitretin—psoriasis	0.000444	0.00124	CcSEcCtD
Aminophylline—Headache—Fluocinolone Acetonide—psoriasis	0.000443	0.00124	CcSEcCtD
Aminophylline—Tension—Mycophenolate mofetil—psoriasis	0.000442	0.00124	CcSEcCtD
Aminophylline—Body temperature increased—Hydroxyurea—psoriasis	0.00044	0.00123	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Methotrexate—psoriasis	0.000438	0.00122	CcSEcCtD
Aminophylline—Nervousness—Mycophenolate mofetil—psoriasis	0.000438	0.00122	CcSEcCtD
Aminophylline—Hypotension—Mycophenolic acid—psoriasis	0.000436	0.00122	CcSEcCtD
Aminophylline—Tremor—Cyclosporine—psoriasis	0.000433	0.00121	CcSEcCtD
Aminophylline—Arrhythmia—Prednisolone—psoriasis	0.000432	0.0012	CcSEcCtD
Aminophylline—Agitation—Cyclosporine—psoriasis	0.000425	0.00119	CcSEcCtD
Aminophylline—Tremor—Mycophenolate mofetil—psoriasis	0.000422	0.00118	CcSEcCtD
Aminophylline—Insomnia—Mycophenolic acid—psoriasis	0.000422	0.00118	CcSEcCtD
Aminophylline—Arrhythmia—Hydrocortisone—psoriasis	0.000422	0.00118	CcSEcCtD
Aminophylline—Nausea—Acitretin—psoriasis	0.000421	0.00118	CcSEcCtD
Aminophylline—Nausea—Fluocinolone Acetonide—psoriasis	0.00042	0.00117	CcSEcCtD
Aminophylline—Agitation—Mycophenolate mofetil—psoriasis	0.000414	0.00116	CcSEcCtD
Aminophylline—Dyspepsia—Mycophenolic acid—psoriasis	0.00041	0.00115	CcSEcCtD
Aminophylline—Hypersensitivity—Hydroxyurea—psoriasis	0.00041	0.00114	CcSEcCtD
Aminophylline—Decreased appetite—Mycophenolic acid—psoriasis	0.000405	0.00113	CcSEcCtD
Aminophylline—Irritability—Methotrexate—psoriasis	0.000405	0.00113	CcSEcCtD
Aminophylline—Convulsion—Cyclosporine—psoriasis	0.0004	0.00112	CcSEcCtD
Aminophylline—Palpitations—Mycophenolate mofetil—psoriasis	0.000398	0.00111	CcSEcCtD
Aminophylline—Arrhythmia—Triamcinolone—psoriasis	0.000397	0.00111	CcSEcCtD
Aminophylline—Hyperglycaemia—Prednisone—psoriasis	0.000396	0.0011	CcSEcCtD
Aminophylline—Anxiety—Cyclosporine—psoriasis	0.000392	0.00109	CcSEcCtD
Aminophylline—Convulsion—Mycophenolate mofetil—psoriasis	0.000391	0.00109	CcSEcCtD
Aminophylline—HDAC2—Levonorgestrel—Hydrocortisone—psoriasis	0.000385	0.0472	CbGdCrCtD
Aminophylline—Anxiety—Mycophenolate mofetil—psoriasis	0.000383	0.00107	CcSEcCtD
Aminophylline—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000381	0.00106	CcSEcCtD
Aminophylline—Diarrhoea—Hydroxyurea—psoriasis	0.000381	0.00106	CcSEcCtD
Aminophylline—Anaphylactic shock—Cyclosporine—psoriasis	0.000377	0.00105	CcSEcCtD
Aminophylline—Infection—Cyclosporine—psoriasis	0.000375	0.00105	CcSEcCtD
Aminophylline—Nervous system disorder—Cyclosporine—psoriasis	0.00037	0.00103	CcSEcCtD
Aminophylline—Abdominal pain—Mycophenolic acid—psoriasis	0.000369	0.00103	CcSEcCtD
Aminophylline—Body temperature increased—Mycophenolic acid—psoriasis	0.000369	0.00103	CcSEcCtD
Aminophylline—Dizziness—Hydroxyurea—psoriasis	0.000368	0.00103	CcSEcCtD
Aminophylline—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000368	0.00103	CcSEcCtD
Aminophylline—Infection—Mycophenolate mofetil—psoriasis	0.000366	0.00102	CcSEcCtD
Aminophylline—Convulsion—Prednisolone—psoriasis	0.000364	0.00102	CcSEcCtD
Aminophylline—Shock—Mycophenolate mofetil—psoriasis	0.000362	0.00101	CcSEcCtD
Aminophylline—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000361	0.00101	CcSEcCtD
Aminophylline—Arrhythmia—Dexamethasone—psoriasis	0.00036	0.00101	CcSEcCtD
Aminophylline—Arrhythmia—Betamethasone—psoriasis	0.00036	0.00101	CcSEcCtD
Aminophylline—Anorexia—Cyclosporine—psoriasis	0.00036	0.001	CcSEcCtD
Aminophylline—Tachycardia—Mycophenolate mofetil—psoriasis	0.000359	0.001	CcSEcCtD
Aminophylline—Alopecia—Dexamethasone—psoriasis	0.000356	0.000994	CcSEcCtD
Aminophylline—Alopecia—Betamethasone—psoriasis	0.000356	0.000994	CcSEcCtD
Aminophylline—Convulsion—Hydrocortisone—psoriasis	0.000356	0.000993	CcSEcCtD
Aminophylline—Vomiting—Hydroxyurea—psoriasis	0.000354	0.000988	CcSEcCtD
Aminophylline—Rash—Hydroxyurea—psoriasis	0.000351	0.00098	CcSEcCtD
Aminophylline—Anorexia—Mycophenolate mofetil—psoriasis	0.000351	0.000979	CcSEcCtD
Aminophylline—Dermatitis—Hydroxyurea—psoriasis	0.000351	0.000979	CcSEcCtD
Aminophylline—Headache—Hydroxyurea—psoriasis	0.000349	0.000974	CcSEcCtD
Aminophylline—Anxiety—Hydrocortisone—psoriasis	0.000349	0.000973	CcSEcCtD
Aminophylline—Hypotension—Mycophenolate mofetil—psoriasis	0.000344	0.00096	CcSEcCtD
Aminophylline—Anaphylactic shock—Prednisolone—psoriasis	0.000343	0.000958	CcSEcCtD
Aminophylline—Insomnia—Cyclosporine—psoriasis	0.000341	0.000952	CcSEcCtD
Aminophylline—Shock—Prednisolone—psoriasis	0.000338	0.000943	CcSEcCtD
Aminophylline—Anaphylactic shock—Hydrocortisone—psoriasis	0.000335	0.000936	CcSEcCtD
Aminophylline—Convulsion—Triamcinolone—psoriasis	0.000335	0.000935	CcSEcCtD
Aminophylline—Tachycardia—Prednisolone—psoriasis	0.000335	0.000935	CcSEcCtD
Aminophylline—Infection—Hydrocortisone—psoriasis	0.000333	0.00093	CcSEcCtD
Aminophylline—Insomnia—Mycophenolate mofetil—psoriasis	0.000333	0.000929	CcSEcCtD
Aminophylline—Dyspepsia—Cyclosporine—psoriasis	0.000332	0.000927	CcSEcCtD
Aminophylline—Nausea—Hydroxyurea—psoriasis	0.000331	0.000923	CcSEcCtD
Aminophylline—Pruritus—Mycophenolic acid—psoriasis	0.00033	0.000921	CcSEcCtD
Aminophylline—Shock—Hydrocortisone—psoriasis	0.00033	0.000921	CcSEcCtD
Aminophylline—Nervous system disorder—Hydrocortisone—psoriasis	0.000329	0.000918	CcSEcCtD
Aminophylline—Decreased appetite—Cyclosporine—psoriasis	0.000328	0.000915	CcSEcCtD
Aminophylline—Tachycardia—Hydrocortisone—psoriasis	0.000327	0.000913	CcSEcCtD
Aminophylline—Flushing—Prednisone—psoriasis	0.000326	0.00091	CcSEcCtD
Aminophylline—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000324	0.000904	CcSEcCtD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000321	0.0049	CbGpPWpGaD
Aminophylline—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00032	0.000893	CcSEcCtD
Aminophylline—Anorexia—Hydrocortisone—psoriasis	0.00032	0.000892	CcSEcCtD
Aminophylline—Diarrhoea—Mycophenolic acid—psoriasis	0.000319	0.000891	CcSEcCtD
Aminophylline—ADORA1—GPCR ligand binding—CCL20—psoriasis	0.000317	0.00483	CbGpPWpGaD
Aminophylline—Anaphylactic shock—Triamcinolone—psoriasis	0.000316	0.000881	CcSEcCtD
Aminophylline—Arrhythmia—Prednisone—psoriasis	0.000314	0.000875	CcSEcCtD
Aminophylline—Infection—Triamcinolone—psoriasis	0.000314	0.000875	CcSEcCtD
Aminophylline—Hypotension—Hydrocortisone—psoriasis	0.000313	0.000874	CcSEcCtD
Aminophylline—ADORA1—Signaling by GPCR—HCAR2—psoriasis	0.000313	0.00477	CbGpPWpGaD
Aminophylline—Haematuria—Methotrexate—psoriasis	0.000312	0.00087	CcSEcCtD
Aminophylline—Shock—Triamcinolone—psoriasis	0.000311	0.000867	CcSEcCtD
Aminophylline—Insomnia—Prednisolone—psoriasis	0.00031	0.000867	CcSEcCtD
Aminophylline—Alopecia—Prednisone—psoriasis	0.00031	0.000866	CcSEcCtD
Aminophylline—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00031	0.00472	CbGpPWpGaD
Aminophylline—HDAC2—Notch Signaling Pathway—NFKB1—psoriasis	0.000309	0.00471	CbGpPWpGaD
Aminophylline—Gastrointestinal pain—Cyclosporine—psoriasis	0.000308	0.000861	CcSEcCtD
Aminophylline—Dizziness—Mycophenolic acid—psoriasis	0.000308	0.000861	CcSEcCtD
Aminophylline—Tachycardia—Triamcinolone—psoriasis	0.000308	0.00086	CcSEcCtD
Aminophylline—Convulsion—Dexamethasone—psoriasis	0.000304	0.000849	CcSEcCtD
Aminophylline—Convulsion—Betamethasone—psoriasis	0.000304	0.000849	CcSEcCtD
Aminophylline—Insomnia—Hydrocortisone—psoriasis	0.000303	0.000846	CcSEcCtD
Aminophylline—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000301	0.00084	CcSEcCtD
Aminophylline—Urticaria—Cyclosporine—psoriasis	0.0003	0.000836	CcSEcCtD
Aminophylline—Abdominal pain—Cyclosporine—psoriasis	0.000298	0.000832	CcSEcCtD
Aminophylline—Body temperature increased—Cyclosporine—psoriasis	0.000298	0.000832	CcSEcCtD
Aminophylline—Anxiety—Dexamethasone—psoriasis	0.000298	0.000831	CcSEcCtD
Aminophylline—Anxiety—Betamethasone—psoriasis	0.000298	0.000831	CcSEcCtD
Aminophylline—Vomiting—Mycophenolic acid—psoriasis	0.000296	0.000828	CcSEcCtD
Aminophylline—HDAC2—Direct p53 effectors—PCNA—psoriasis	0.000296	0.00452	CbGpPWpGaD
Aminophylline—Dyspepsia—Hydrocortisone—psoriasis	0.000295	0.000824	CcSEcCtD
Aminophylline—HDAC2—Regulation of Telomerase—JUN—psoriasis	0.000294	0.00448	CbGpPWpGaD
Aminophylline—Rash—Mycophenolic acid—psoriasis	0.000294	0.000821	CcSEcCtD
Aminophylline—Dermatitis—Mycophenolic acid—psoriasis	0.000294	0.00082	CcSEcCtD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—IFNG—psoriasis	0.000293	0.00447	CbGpPWpGaD
Aminophylline—Urticaria—Mycophenolate mofetil—psoriasis	0.000292	0.000816	CcSEcCtD
Aminophylline—Headache—Mycophenolic acid—psoriasis	0.000292	0.000815	CcSEcCtD
Aminophylline—Decreased appetite—Hydrocortisone—psoriasis	0.000291	0.000813	CcSEcCtD
Aminophylline—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000291	0.000812	CcSEcCtD
Aminophylline—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000291	0.000812	CcSEcCtD
Aminophylline—Anaphylactic shock—Dexamethasone—psoriasis	0.000286	0.0008	CcSEcCtD
Aminophylline—Anaphylactic shock—Betamethasone—psoriasis	0.000286	0.0008	CcSEcCtD
Aminophylline—Insomnia—Triamcinolone—psoriasis	0.000286	0.000797	CcSEcCtD
Aminophylline—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000285	0.00435	CbGpPWpGaD
Aminophylline—Infection—Betamethasone—psoriasis	0.000285	0.000794	CcSEcCtD
Aminophylline—Infection—Dexamethasone—psoriasis	0.000285	0.000794	CcSEcCtD
Aminophylline—HDAC2—Regulation of Telomerase—NFKB1—psoriasis	0.000283	0.00432	CbGpPWpGaD
Aminophylline—Shock—Dexamethasone—psoriasis	0.000282	0.000787	CcSEcCtD
Aminophylline—Shock—Betamethasone—psoriasis	0.000282	0.000787	CcSEcCtD
Aminophylline—Nervous system disorder—Betamethasone—psoriasis	0.000281	0.000784	CcSEcCtD
Aminophylline—Nervous system disorder—Dexamethasone—psoriasis	0.000281	0.000784	CcSEcCtD
Aminophylline—Agitation—Prednisone—psoriasis	0.000281	0.000784	CcSEcCtD
Aminophylline—Tachycardia—Betamethasone—psoriasis	0.00028	0.00078	CcSEcCtD
Aminophylline—Tachycardia—Dexamethasone—psoriasis	0.00028	0.00078	CcSEcCtD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000279	0.00426	CbGpPWpGaD
Aminophylline—Hypersensitivity—Cyclosporine—psoriasis	0.000278	0.000776	CcSEcCtD
Aminophylline—Dyspepsia—Triamcinolone—psoriasis	0.000278	0.000776	CcSEcCtD
Aminophylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—psoriasis	0.000278	0.00424	CbGpPWpGaD
Aminophylline—HDAC2—Notch Signaling Pathway—STAT3—psoriasis	0.000278	0.00423	CbGpPWpGaD
Aminophylline—Nausea—Mycophenolic acid—psoriasis	0.000277	0.000773	CcSEcCtD
Aminophylline—HDAC2—Signaling events mediated by HDAC Class I—NFKB1—psoriasis	0.000277	0.00422	CbGpPWpGaD
Aminophylline—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000274	0.000765	CcSEcCtD
Aminophylline—Anorexia—Dexamethasone—psoriasis	0.000273	0.000762	CcSEcCtD
Aminophylline—Anorexia—Betamethasone—psoriasis	0.000273	0.000762	CcSEcCtD
Aminophylline—Urticaria—Prednisolone—psoriasis	0.000273	0.000761	CcSEcCtD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	0.000272	0.00415	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—ITGAL—psoriasis	0.000271	0.00414	CbGpPWpGaD
Aminophylline—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000271	0.000757	CcSEcCtD
Aminophylline—Hypotension—Dexamethasone—psoriasis	0.000268	0.000747	CcSEcCtD
Aminophylline—Hypotension—Betamethasone—psoriasis	0.000268	0.000747	CcSEcCtD
Aminophylline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000267	0.00407	CbGpPWpGaD
Aminophylline—Pruritus—Cyclosporine—psoriasis	0.000267	0.000745	CcSEcCtD
Aminophylline—Urticaria—Hydrocortisone—psoriasis	0.000266	0.000743	CcSEcCtD
Aminophylline—ADORA2A—GPCR downstream signaling—HCAR2—psoriasis	0.000266	0.00406	CbGpPWpGaD
Aminophylline—Abdominal pain—Hydrocortisone—psoriasis	0.000265	0.00074	CcSEcCtD
Aminophylline—Body temperature increased—Hydrocortisone—psoriasis	0.000265	0.00074	CcSEcCtD
Aminophylline—Convulsion—Prednisone—psoriasis	0.000265	0.000739	CcSEcCtD
Aminophylline—Pruritus—Mycophenolate mofetil—psoriasis	0.00026	0.000727	CcSEcCtD
Aminophylline—Anxiety—Prednisone—psoriasis	0.000259	0.000724	CcSEcCtD
Aminophylline—Alopecia—Methotrexate—psoriasis	0.000259	0.000724	CcSEcCtD
Aminophylline—Insomnia—Dexamethasone—psoriasis	0.000259	0.000723	CcSEcCtD
Aminophylline—Insomnia—Betamethasone—psoriasis	0.000259	0.000723	CcSEcCtD
Aminophylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	0.000258	0.00394	CbGpPWpGaD
Aminophylline—Diarrhoea—Cyclosporine—psoriasis	0.000258	0.00072	CcSEcCtD
Aminophylline—HDAC2—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	0.000256	0.0039	CbGpPWpGaD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—JUN—psoriasis	0.000253	0.00386	CbGpPWpGaD
Aminophylline—Hypersensitivity—Prednisolone—psoriasis	0.000253	0.000706	CcSEcCtD
Aminophylline—Dyspepsia—Betamethasone—psoriasis	0.000252	0.000704	CcSEcCtD
Aminophylline—Dyspepsia—Dexamethasone—psoriasis	0.000252	0.000704	CcSEcCtD
Aminophylline—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000252	0.000703	CcSEcCtD
Aminophylline—Urticaria—Triamcinolone—psoriasis	0.000251	0.0007	CcSEcCtD
Aminophylline—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.00025	0.00382	CbGpPWpGaD
Aminophylline—Body temperature increased—Triamcinolone—psoriasis	0.00025	0.000697	CcSEcCtD
Aminophylline—Dizziness—Cyclosporine—psoriasis	0.000249	0.000696	CcSEcCtD
Aminophylline—Anaphylactic shock—Prednisone—psoriasis	0.000249	0.000696	CcSEcCtD
Aminophylline—Decreased appetite—Betamethasone—psoriasis	0.000249	0.000695	CcSEcCtD
Aminophylline—Decreased appetite—Dexamethasone—psoriasis	0.000249	0.000695	CcSEcCtD
Aminophylline—HDAC2—Signaling events mediated by HDAC Class I—STAT3—psoriasis	0.000249	0.00379	CbGpPWpGaD
Aminophylline—Infection—Prednisone—psoriasis	0.000248	0.000692	CcSEcCtD
Aminophylline—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000247	0.00377	CbGpPWpGaD
Aminophylline—Hypersensitivity—Hydrocortisone—psoriasis	0.000247	0.000689	CcSEcCtD
Aminophylline—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000247	0.00376	CbGpPWpGaD
Aminophylline—Shock—Prednisone—psoriasis	0.000245	0.000685	CcSEcCtD
Aminophylline—Nervous system disorder—Prednisone—psoriasis	0.000245	0.000683	CcSEcCtD
Aminophylline—ADORA2A—GPCR ligand binding—CCL20—psoriasis	0.000245	0.00373	CbGpPWpGaD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	0.000244	0.00372	CbGpPWpGaD
Aminophylline—HDAC2—p75 NTR receptor-mediated signalling—NFKB1—psoriasis	0.000244	0.00372	CbGpPWpGaD
Aminophylline—Tachycardia—Prednisone—psoriasis	0.000243	0.00068	CcSEcCtD
Aminophylline—Dizziness—Mycophenolate mofetil—psoriasis	0.000243	0.000679	CcSEcCtD
Aminophylline—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000243	0.0037	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—HCAR2—psoriasis	0.000242	0.00368	CbGpPWpGaD
Aminophylline—ADORA1—Circadian rythm related genes—LEP—psoriasis	0.000241	0.00367	CbGpPWpGaD
Aminophylline—Vomiting—Cyclosporine—psoriasis	0.00024	0.000669	CcSEcCtD
Aminophylline—Rash—Cyclosporine—psoriasis	0.000238	0.000664	CcSEcCtD
Aminophylline—Anorexia—Prednisone—psoriasis	0.000238	0.000664	CcSEcCtD
Aminophylline—Dermatitis—Cyclosporine—psoriasis	0.000238	0.000663	CcSEcCtD
Aminophylline—Pruritus—Hydrocortisone—psoriasis	0.000237	0.000662	CcSEcCtD
Aminophylline—Headache—Cyclosporine—psoriasis	0.000236	0.00066	CcSEcCtD
Aminophylline—Gastrointestinal pain—Dexamethasone—psoriasis	0.000234	0.000654	CcSEcCtD
Aminophylline—Gastrointestinal pain—Betamethasone—psoriasis	0.000234	0.000654	CcSEcCtD
Aminophylline—Vomiting—Mycophenolate mofetil—psoriasis	0.000234	0.000653	CcSEcCtD
Aminophylline—Hypersensitivity—Triamcinolone—psoriasis	0.000233	0.000649	CcSEcCtD
Aminophylline—Rash—Mycophenolate mofetil—psoriasis	0.000232	0.000648	CcSEcCtD
Aminophylline—Dermatitis—Mycophenolate mofetil—psoriasis	0.000232	0.000647	CcSEcCtD
Aminophylline—Headache—Mycophenolate mofetil—psoriasis	0.000231	0.000643	CcSEcCtD
Aminophylline—Diarrhoea—Hydrocortisone—psoriasis	0.000229	0.00064	CcSEcCtD
Aminophylline—Urticaria—Dexamethasone—psoriasis	0.000228	0.000635	CcSEcCtD
Aminophylline—Urticaria—Betamethasone—psoriasis	0.000228	0.000635	CcSEcCtD
Aminophylline—Dizziness—Prednisolone—psoriasis	0.000227	0.000634	CcSEcCtD
Aminophylline—Body temperature increased—Dexamethasone—psoriasis	0.000226	0.000632	CcSEcCtD
Aminophylline—Abdominal pain—Dexamethasone—psoriasis	0.000226	0.000632	CcSEcCtD
Aminophylline—Abdominal pain—Betamethasone—psoriasis	0.000226	0.000632	CcSEcCtD
Aminophylline—Body temperature increased—Betamethasone—psoriasis	0.000226	0.000632	CcSEcCtD
Aminophylline—Insomnia—Prednisone—psoriasis	0.000226	0.00063	CcSEcCtD
Aminophylline—ADORA1—Circadian rythm related genes—NOS2—psoriasis	0.000224	0.00342	CbGpPWpGaD
Aminophylline—Nausea—Cyclosporine—psoriasis	0.000224	0.000625	CcSEcCtD
Aminophylline—Pruritus—Triamcinolone—psoriasis	0.000223	0.000623	CcSEcCtD
Aminophylline—Dizziness—Hydrocortisone—psoriasis	0.000222	0.000619	CcSEcCtD
Aminophylline—Convulsion—Methotrexate—psoriasis	0.000221	0.000618	CcSEcCtD
Aminophylline—Dyspepsia—Prednisone—psoriasis	0.00022	0.000613	CcSEcCtD
Aminophylline—Nausea—Mycophenolate mofetil—psoriasis	0.000219	0.00061	CcSEcCtD
Aminophylline—ADORA2B—Signaling Pathways—HCAR2—psoriasis	0.000217	0.00331	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—ITGAL—psoriasis	0.000217	0.00331	CbGpPWpGaD
Aminophylline—Decreased appetite—Prednisone—psoriasis	0.000217	0.000605	CcSEcCtD
Aminophylline—Rash—Prednisolone—psoriasis	0.000216	0.000604	CcSEcCtD
Aminophylline—Dermatitis—Prednisolone—psoriasis	0.000216	0.000604	CcSEcCtD
Aminophylline—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000216	0.00329	CbGpPWpGaD
Aminophylline—HDAC2—Signaling events mediated by HDAC Class I—TNF—psoriasis	0.000215	0.00328	CbGpPWpGaD
Aminophylline—Headache—Prednisolone—psoriasis	0.000215	0.0006	CcSEcCtD
Aminophylline—Vomiting—Hydrocortisone—psoriasis	0.000213	0.000595	CcSEcCtD
Aminophylline—Rash—Hydrocortisone—psoriasis	0.000211	0.00059	CcSEcCtD
Aminophylline—Dermatitis—Hydrocortisone—psoriasis	0.000211	0.000589	CcSEcCtD
Aminophylline—ADORA2B—GPCR downstream signaling—CCL20—psoriasis	0.00021	0.00321	CbGpPWpGaD
Aminophylline—Headache—Hydrocortisone—psoriasis	0.00021	0.000586	CcSEcCtD
Aminophylline—ADORA1—Circadian rythm related genes—PPARG—psoriasis	0.00021	0.0032	CbGpPWpGaD
Aminophylline—Dizziness—Triamcinolone—psoriasis	0.000209	0.000583	CcSEcCtD
Aminophylline—Anaphylactic shock—Methotrexate—psoriasis	0.000208	0.000582	CcSEcCtD
Aminophylline—Infection—Methotrexate—psoriasis	0.000207	0.000578	CcSEcCtD
Aminophylline—HDAC2—Neural Crest Differentiation—NFKB1—psoriasis	0.000206	0.00315	CbGpPWpGaD
Aminophylline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000206	0.00314	CbGpPWpGaD
Aminophylline—Nervous system disorder—Methotrexate—psoriasis	0.000204	0.000571	CcSEcCtD
Aminophylline—Gastrointestinal pain—Prednisone—psoriasis	0.000204	0.000569	CcSEcCtD
Aminophylline—Nausea—Prednisolone—psoriasis	0.000204	0.000569	CcSEcCtD
Aminophylline—Pruritus—Dexamethasone—psoriasis	0.000203	0.000566	CcSEcCtD
Aminophylline—Pruritus—Betamethasone—psoriasis	0.000203	0.000566	CcSEcCtD
Aminophylline—HDAC2—Signaling by NOTCH—JUN—psoriasis	0.000202	0.00307	CbGpPWpGaD
Aminophylline—Vomiting—Triamcinolone—psoriasis	0.000201	0.00056	CcSEcCtD
Aminophylline—HDAC2—Circadian rythm related genes—LEP—psoriasis	0.0002	0.00305	CbGpPWpGaD
Aminophylline—Nausea—Hydrocortisone—psoriasis	0.000199	0.000556	CcSEcCtD
Aminophylline—Rash—Triamcinolone—psoriasis	0.000199	0.000556	CcSEcCtD
Aminophylline—Dermatitis—Triamcinolone—psoriasis	0.000199	0.000555	CcSEcCtD
Aminophylline—Anorexia—Methotrexate—psoriasis	0.000199	0.000555	CcSEcCtD
Aminophylline—Urticaria—Prednisone—psoriasis	0.000198	0.000553	CcSEcCtD
Aminophylline—Headache—Triamcinolone—psoriasis	0.000198	0.000552	CcSEcCtD
Aminophylline—PDE4A—Signaling Pathways—HCAR2—psoriasis	0.000197	0.00301	CbGpPWpGaD
Aminophylline—Body temperature increased—Prednisone—psoriasis	0.000197	0.00055	CcSEcCtD
Aminophylline—Abdominal pain—Prednisone—psoriasis	0.000197	0.00055	CcSEcCtD
Aminophylline—Diarrhoea—Dexamethasone—psoriasis	0.000196	0.000547	CcSEcCtD
Aminophylline—Diarrhoea—Betamethasone—psoriasis	0.000196	0.000547	CcSEcCtD
Aminophylline—Hypotension—Methotrexate—psoriasis	0.000195	0.000544	CcSEcCtD
Aminophylline—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000193	0.00295	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—HCAR2—psoriasis	0.000192	0.00293	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CCL20—psoriasis	0.000191	0.00291	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—CCL20—psoriasis	0.000191	0.00291	CbGpPWpGaD
Aminophylline—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000191	0.00291	CbGpPWpGaD
Aminophylline—Dizziness—Betamethasone—psoriasis	0.000189	0.000529	CcSEcCtD
Aminophylline—Dizziness—Dexamethasone—psoriasis	0.000189	0.000529	CcSEcCtD
Aminophylline—Insomnia—Methotrexate—psoriasis	0.000189	0.000526	CcSEcCtD
Aminophylline—ADORA2B—Signaling Pathways—TAGAP—psoriasis	0.000188	0.00287	CbGpPWpGaD
Aminophylline—Nausea—Triamcinolone—psoriasis	0.000188	0.000523	CcSEcCtD
Aminophylline—HDAC2—Circadian rythm related genes—NOS2—psoriasis	0.000186	0.00284	CbGpPWpGaD
Aminophylline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000186	0.00284	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—LEP—psoriasis	0.000186	0.00284	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—CCL20—psoriasis	0.000186	0.00283	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—HCAR2—psoriasis	0.000185	0.00282	CbGpPWpGaD
Aminophylline—Hypersensitivity—Prednisone—psoriasis	0.000184	0.000513	CcSEcCtD
Aminophylline—Dyspepsia—Methotrexate—psoriasis	0.000184	0.000512	CcSEcCtD
Aminophylline—Vomiting—Dexamethasone—psoriasis	0.000182	0.000508	CcSEcCtD
Aminophylline—Vomiting—Betamethasone—psoriasis	0.000182	0.000508	CcSEcCtD
Aminophylline—Decreased appetite—Methotrexate—psoriasis	0.000181	0.000506	CcSEcCtD
Aminophylline—Rash—Betamethasone—psoriasis	0.000181	0.000504	CcSEcCtD
Aminophylline—Rash—Dexamethasone—psoriasis	0.000181	0.000504	CcSEcCtD
Aminophylline—Dermatitis—Dexamethasone—psoriasis	0.00018	0.000504	CcSEcCtD
Aminophylline—Dermatitis—Betamethasone—psoriasis	0.00018	0.000504	CcSEcCtD
Aminophylline—Headache—Betamethasone—psoriasis	0.000179	0.000501	CcSEcCtD
Aminophylline—Headache—Dexamethasone—psoriasis	0.000179	0.000501	CcSEcCtD
Aminophylline—ADORA1—GPCR downstream signaling—CCL20—psoriasis	0.000179	0.00273	CbGpPWpGaD
Aminophylline—Pruritus—Prednisone—psoriasis	0.000176	0.000493	CcSEcCtD
Aminophylline—HDAC2—Circadian rythm related genes—PPARG—psoriasis	0.000174	0.00266	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CCL20—psoriasis	0.000174	0.00265	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—NOS2—psoriasis	0.000173	0.00264	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TAGAP—psoriasis	0.000171	0.00261	CbGpPWpGaD
Aminophylline—Diarrhoea—Prednisone—psoriasis	0.000171	0.000476	CcSEcCtD
Aminophylline—Gastrointestinal pain—Methotrexate—psoriasis	0.00017	0.000476	CcSEcCtD
Aminophylline—Nausea—Betamethasone—psoriasis	0.00017	0.000475	CcSEcCtD
Aminophylline—Nausea—Dexamethasone—psoriasis	0.00017	0.000475	CcSEcCtD
Aminophylline—PDE3A—Signaling by GPCR—CCL20—psoriasis	0.000169	0.00257	CbGpPWpGaD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—TP53—psoriasis	0.000167	0.00255	CbGpPWpGaD
Aminophylline—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000167	0.00254	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TAGAP—psoriasis	0.000166	0.00254	CbGpPWpGaD
Aminophylline—Urticaria—Methotrexate—psoriasis	0.000166	0.000462	CcSEcCtD
Aminophylline—HDAC2—Direct p53 effectors—JUN—psoriasis	0.000165	0.00252	CbGpPWpGaD
Aminophylline—Dizziness—Prednisone—psoriasis	0.000165	0.00046	CcSEcCtD
Aminophylline—Body temperature increased—Methotrexate—psoriasis	0.000165	0.00046	CcSEcCtD
Aminophylline—Abdominal pain—Methotrexate—psoriasis	0.000165	0.00046	CcSEcCtD
Aminophylline—ADORA1—Signaling by GPCR—CCL20—psoriasis	0.000163	0.00248	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—PPARG—psoriasis	0.000162	0.00247	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TAGAP—psoriasis	0.00016	0.00244	CbGpPWpGaD
Aminophylline—Vomiting—Prednisone—psoriasis	0.000159	0.000443	CcSEcCtD
Aminophylline—Rash—Prednisone—psoriasis	0.000157	0.000439	CcSEcCtD
Aminophylline—Dermatitis—Prednisone—psoriasis	0.000157	0.000439	CcSEcCtD
Aminophylline—Headache—Prednisone—psoriasis	0.000156	0.000436	CcSEcCtD
Aminophylline—Hypersensitivity—Methotrexate—psoriasis	0.000154	0.000429	CcSEcCtD
Aminophylline—HDAC2—Signaling Pathways—HCAR2—psoriasis	0.000154	0.00234	CbGpPWpGaD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—IL6—psoriasis	0.000153	0.00233	CbGpPWpGaD
Aminophylline—ADORA1—Circadian rythm related genes—JUN—psoriasis	0.000149	0.00227	CbGpPWpGaD
Aminophylline—Nausea—Prednisone—psoriasis	0.000148	0.000414	CcSEcCtD
Aminophylline—Pruritus—Methotrexate—psoriasis	0.000147	0.000412	CcSEcCtD
Aminophylline—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	0.000144	0.0022	CbGpPWpGaD
Aminophylline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000144	0.00219	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—HCAR2—psoriasis	0.000143	0.00218	CbGpPWpGaD
Aminophylline—Diarrhoea—Methotrexate—psoriasis	0.000143	0.000398	CcSEcCtD
Aminophylline—ADORA1—G alpha (i) signalling events—CXCL8—psoriasis	0.000141	0.00215	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—NFKBIA—psoriasis	0.000141	0.00214	CbGpPWpGaD
Aminophylline—HDAC2—Cell Cycle—TP53—psoriasis	0.00014	0.00214	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—TYK2—psoriasis	0.000139	0.00212	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—CCL20—psoriasis	0.000138	0.00211	CbGpPWpGaD
Aminophylline—Dizziness—Methotrexate—psoriasis	0.000138	0.000385	CcSEcCtD
Aminophylline—HDAC2—Signaling by NOTCH—TP53—psoriasis	0.000133	0.00203	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TAGAP—psoriasis	0.000133	0.00203	CbGpPWpGaD
Aminophylline—Vomiting—Methotrexate—psoriasis	0.000133	0.00037	CcSEcCtD
Aminophylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000132	0.00201	CbGpPWpGaD
Aminophylline—Rash—Methotrexate—psoriasis	0.000131	0.000367	CcSEcCtD
Aminophylline—Dermatitis—Methotrexate—psoriasis	0.000131	0.000367	CcSEcCtD
Aminophylline—ADORA2A—Signaling by NGF—NFKBIA—psoriasis	0.000131	0.00199	CbGpPWpGaD
Aminophylline—Headache—Methotrexate—psoriasis	0.000131	0.000365	CcSEcCtD
Aminophylline—ADORA2A—Signaling by GPCR—CCL20—psoriasis	0.000125	0.00191	CbGpPWpGaD
Aminophylline—Nausea—Methotrexate—psoriasis	0.000124	0.000346	CcSEcCtD
Aminophylline—ADORA2A—Signaling Pathways—TAGAP—psoriasis	0.000124	0.00189	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—JUN—psoriasis	0.000124	0.00188	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.00012	0.00183	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—TYK2—psoriasis	0.000115	0.00176	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—JUN—psoriasis	0.000115	0.00175	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCL20—psoriasis	0.000113	0.00172	CbGpPWpGaD
Aminophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000112	0.00171	CbGpPWpGaD
Aminophylline—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—psoriasis	0.000112	0.0017	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—NOS2—psoriasis	0.000111	0.0017	CbGpPWpGaD
Aminophylline—HDAC2—Direct p53 effectors—TP53—psoriasis	0.000109	0.00166	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—TYK2—psoriasis	0.000107	0.00163	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—CARM1—psoriasis	0.000104	0.00159	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000104	0.00158	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCL20—psoriasis	0.000103	0.00156	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR ligand binding—CXCL8—psoriasis	0.000101	0.00153	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	9.99e-05	0.00152	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCL20—psoriasis	9.97e-05	0.00152	CbGpPWpGaD
Aminophylline—ADORA1—Circadian rythm related genes—TP53—psoriasis	9.82e-05	0.0015	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	9.74e-05	0.00149	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCL20—psoriasis	9.6e-05	0.00146	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	9.06e-05	0.00138	CbGpPWpGaD
Aminophylline—ADORA1—Circadian rythm related genes—IL6—psoriasis	8.99e-05	0.00137	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—NFKB1—psoriasis	8.97e-05	0.00137	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—NOS2—psoriasis	8.91e-05	0.00136	CbGpPWpGaD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	8.67e-05	0.00132	CbGpPWpGaD
Aminophylline—ADORA1—GPCR ligand binding—CXCL8—psoriasis	8.55e-05	0.0013	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NDUFA5—psoriasis	8.38e-05	0.00128	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—NFKB1—psoriasis	8.34e-05	0.00127	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—TP53—psoriasis	8.16e-05	0.00124	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—STAT3—psoriasis	8.06e-05	0.00123	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCL20—psoriasis	7.97e-05	0.00122	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	7.77e-05	0.00118	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	7.77e-05	0.00118	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—TP53—psoriasis	7.58e-05	0.00116	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—STAT3—psoriasis	7.49e-05	0.00114	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—IL6—psoriasis	7.47e-05	0.00114	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCL20—psoriasis	7.41e-05	0.00113	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CYP2S1—psoriasis	7.13e-05	0.00109	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—IL6—psoriasis	6.94e-05	0.00106	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	6.81e-05	0.00104	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—CXCL8—psoriasis	6.6e-05	0.00101	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—VEGFA—psoriasis	6.45e-05	0.000984	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—VDR—psoriasis	6.23e-05	0.000949	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—SOCS1—psoriasis	6.22e-05	0.000948	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—TYK2—psoriasis	5.93e-05	0.000904	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—CXCL8—psoriasis	5.68e-05	0.000867	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SOCS1—psoriasis	5.65e-05	0.000861	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—IL6—psoriasis	5.63e-05	0.000859	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SOCS1—psoriasis	5.49e-05	0.000837	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—TYK2—psoriasis	5.38e-05	0.000821	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SOCS1—psoriasis	5.29e-05	0.000806	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—TYK2—psoriasis	5.24e-05	0.000798	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—IL6—psoriasis	5.24e-05	0.000798	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—CXCL8—psoriasis	5.16e-05	0.000787	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—CXCL8—psoriasis	5.16e-05	0.000787	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—VEGFA—psoriasis	5.16e-05	0.000786	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—TYK2—psoriasis	5.04e-05	0.000768	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NDUFA5—psoriasis	5.04e-05	0.000768	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—CXCL8—psoriasis	5.02e-05	0.000765	CbGpPWpGaD
Aminophylline—HDAC2—Disease—HLA-A—psoriasis	4.96e-05	0.000756	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—TP53—psoriasis	4.88e-05	0.000743	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—CXCL8—psoriasis	4.83e-05	0.000737	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.7e-05	0.000716	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—CXCL8—psoriasis	4.69e-05	0.000715	CbGpPWpGaD
Aminophylline—HDAC2—Disease—APOE—psoriasis	4.63e-05	0.000705	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—LEP—psoriasis	4.59e-05	0.0007	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—APOE—psoriasis	4.59e-05	0.0007	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—CXCL8—psoriasis	4.56e-05	0.000695	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SOCS1—psoriasis	4.39e-05	0.000669	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—CXCL8—psoriasis	4.39e-05	0.000669	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—PPARG—psoriasis	4.34e-05	0.000662	CbGpPWpGaD
Aminophylline—HDAC2—Disease—NOS2—psoriasis	4.31e-05	0.000657	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP2S1—psoriasis	4.28e-05	0.000653	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NFKBIA—psoriasis	4.28e-05	0.000652	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—APOE—psoriasis	4.17e-05	0.000635	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—LEP—psoriasis	4.17e-05	0.000635	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SOCS1—psoriasis	4.08e-05	0.000622	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—LEP—psoriasis	4.05e-05	0.000618	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—APOE—psoriasis	4.05e-05	0.000618	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—APOE—psoriasis	3.9e-05	0.000595	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—LEP—psoriasis	3.9e-05	0.000595	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—TP53—psoriasis	3.9e-05	0.000594	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—TYK2—psoriasis	3.89e-05	0.000593	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NDUFA5—psoriasis	3.89e-05	0.000593	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NFKBIA—psoriasis	3.88e-05	0.000592	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NFKBIA—psoriasis	3.78e-05	0.000576	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—CXCL8—psoriasis	3.73e-05	0.000569	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NFKBIA—psoriasis	3.64e-05	0.000554	CbGpPWpGaD
Aminophylline—HDAC2—Disease—TYK2—psoriasis	3.53e-05	0.000538	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TYK2—psoriasis	3.5e-05	0.000534	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CARM1—psoriasis	3.48e-05	0.000531	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CXCL8—psoriasis	3.39e-05	0.000517	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP2S1—psoriasis	3.31e-05	0.000504	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—LEP—psoriasis	3.24e-05	0.000494	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—APOE—psoriasis	3.24e-05	0.000494	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CD4—psoriasis	3.19e-05	0.000487	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TYK2—psoriasis	3.18e-05	0.000485	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TYK2—psoriasis	3.09e-05	0.000472	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CXCL8—psoriasis	3.05e-05	0.000465	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NFKBIA—psoriasis	3.02e-05	0.00046	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—LEP—psoriasis	3.01e-05	0.000459	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—APOE—psoriasis	3.01e-05	0.000459	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TYK2—psoriasis	2.98e-05	0.000454	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—IL6—psoriasis	2.9e-05	0.000442	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—JUN—psoriasis	2.83e-05	0.000432	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NFKBIA—psoriasis	2.81e-05	0.000428	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CXCL8—psoriasis	2.77e-05	0.000422	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NFKB1—psoriasis	2.73e-05	0.000416	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CXCL8—psoriasis	2.69e-05	0.000411	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—IL6—psoriasis	2.63e-05	0.000401	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CXCL8—psoriasis	2.59e-05	0.000395	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—JUN—psoriasis	2.57e-05	0.000392	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—IL6—psoriasis	2.56e-05	0.00039	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—JUN—psoriasis	2.5e-05	0.000382	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NFKB1—psoriasis	2.48e-05	0.000378	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—VEGFA—psoriasis	2.48e-05	0.000378	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TYK2—psoriasis	2.47e-05	0.000377	CbGpPWpGaD
Aminophylline—HDAC2—Disease—STAT3—psoriasis	2.47e-05	0.000377	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—IL6—psoriasis	2.47e-05	0.000376	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—STAT3—psoriasis	2.45e-05	0.000374	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NFKB1—psoriasis	2.41e-05	0.000367	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—JUN—psoriasis	2.41e-05	0.000367	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NFKB1—psoriasis	2.32e-05	0.000354	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TYK2—psoriasis	2.3e-05	0.000351	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—VEGFA—psoriasis	2.25e-05	0.000343	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.24e-05	0.000342	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—STAT3—psoriasis	2.23e-05	0.000339	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—VEGFA—psoriasis	2.19e-05	0.000334	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—STAT3—psoriasis	2.17e-05	0.00033	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CXCL8—psoriasis	2.15e-05	0.000328	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CAT—psoriasis	2.14e-05	0.000326	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—VEGFA—psoriasis	2.11e-05	0.000321	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CARM1—psoriasis	2.09e-05	0.000319	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—STAT3—psoriasis	2.08e-05	0.000318	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CXCL8—psoriasis	2e-05	0.000305	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—JUN—psoriasis	2e-05	0.000305	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.96e-05	0.000298	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NFKB1—psoriasis	1.93e-05	0.000294	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL6—psoriasis	1.9e-05	0.00029	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—psoriasis	1.87e-05	0.000285	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—JUN—psoriasis	1.86e-05	0.000284	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NFKB1—psoriasis	1.79e-05	0.000273	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—VEGFA—psoriasis	1.75e-05	0.000267	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—STAT3—psoriasis	1.73e-05	0.000264	CbGpPWpGaD
Aminophylline—HDAC2—Disease—IL6—psoriasis	1.73e-05	0.000263	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL6—psoriasis	1.71e-05	0.000261	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—psoriasis	1.7e-05	0.000259	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—APOE—psoriasis	1.66e-05	0.000254	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—psoriasis	1.65e-05	0.000252	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—VEGFA—psoriasis	1.63e-05	0.000248	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CARM1—psoriasis	1.61e-05	0.000246	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—STAT3—psoriasis	1.61e-05	0.000245	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—psoriasis	1.59e-05	0.000243	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL6—psoriasis	1.56e-05	0.000237	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL6—psoriasis	1.51e-05	0.000231	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL6—psoriasis	1.46e-05	0.000222	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PPARG—psoriasis	1.45e-05	0.000221	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—psoriasis	1.32e-05	0.000201	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CAT—psoriasis	1.29e-05	0.000196	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—psoriasis	1.23e-05	0.000187	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL6—psoriasis	1.21e-05	0.000184	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL6—psoriasis	1.12e-05	0.000171	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOE—psoriasis	1e-05	0.000152	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CAT—psoriasis	9.93e-06	0.000151	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPARG—psoriasis	8.71e-06	0.000133	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOE—psoriasis	7.72e-06	0.000118	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPARG—psoriasis	6.72e-06	0.000102	CbGpPWpGaD
